Related Experiment Video
Updated: Feb 19, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Role of LFA-1 and ICAM-1 in Cancer
Manuel Reina1,2, Enric Espel3,4
1Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Diagonal 643, 08028 Barcelona, Spain. mreina@ub.edu.
Insights
This review explores how lymphocyte function-associated antigen-1 (LFA-1) and its ligand ICAM-1 impact cancer by mediating leukocyte-tumor interactions. It also examines LFA-1
Area of Science:
- Immunology and Cancer Biology
- Cellular Adhesion Molecules
- Leukocyte-Tumor Interactions
Background:
- Lymphocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18, is an integrin exclusively expressed on leukocytes.
- LFA-1 plays a crucial role in immune cell trafficking and interactions.
- Its primary ligand, ICAM-1 (CD54), is involved in various cellular processes, including immune responses and cancer progression.
Purpose of the Study:
- To review the multifaceted roles of LFA-1 and ICAM-1 in cancer.
- To elucidate how LFA-1 mediates leukocyte interactions with tumor cells.
- To discuss the implications of LFA-1 in B-cell chronic lymphocytic leukemia and exosome-mediated tumor metastasis.
Main Methods:
- Comprehensive literature review of studies investigating LFA-1, ICAM-1, and cancer.
- Analysis of research focusing on lymphocyte and myeloid cell functions in tumor microenvironments.
- Examination of data related to LFA-1's role in specific hematological malignancies and metastatic processes.
Main Results:
- LFA-1 mediates critical interactions between leukocytes and tumor cells, influencing immune surveillance and evasion.
- ICAM-1 contributes to tumor dynamics, with some functions independent of LFA-1 binding.
- Exosomes expressing LFA-1 are implicated in promoting tumor growth and metastasis.
Conclusions:
- LFA-1 and ICAM-1 are significant players in cancer biology, affecting immune cell behavior and tumor progression.
- Targeting LFA-1-ICAM-1 interactions presents potential therapeutic strategies for various cancers.
- Further research into LFA-1's role in leukemia and exosome-mediated metastasis is warranted.
Abstract:
The lymphocyte function-associated antigen-1 (LFA-1) (also known as CD11a/CD18 and αLβ₂), is just one of many integrins in the human body, but its significance is derived from its exclusive presence in leukocytes. In this review, we summarize the studies relating LFA-1 and its major ligand ICAM-1 (or CD54) with cancer, through the function of lymphocytes and myeloid cells on tumor cells. We consider how LFA-1 mediates the interaction of leukocytes with tumors and the role of ICAM-1 in tumor dynamics, which can be independent of its interaction with LFA-1. We also offer a more detailed examination of the role of LFA-1 within B-cell chronic lymphocytic leukemia. Finally, we discuss the role that exosomes harboring LFA-1 play in tumor growth and metastasis.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cancer Cell Migration through Invadopodia
lncRNA - Long Non-coding RNAs
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Intracellular Signaling Affects Focal Adhesions
Some...

